The challenges of clinical trials in fragile X syndrome

RATIONALE: Advances in understanding the underlying mechanisms of conditions such as fragile X syndrome (FXS) and autism spectrum disorders have revealed heterogeneous populations. Recent trials of novel FXS therapies have highlighted several challenges including subpopulations with possibly differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacquemont, Sébastien, Berry-Kravis, Elizabeth, Hagerman, Randi, von Raison, Florian, Gasparini, Fabrizio, Apostol, George, Ufer, Mike, Des Portes, Vincent, Gomez-Mancilla, Baltazar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932172/
https://www.ncbi.nlm.nih.gov/pubmed/24173622
http://dx.doi.org/10.1007/s00213-013-3289-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932172/
https://www.ncbi.nlm.nih.gov/pubmed/24173622
http://dx.doi.org/10.1007/s00213-013-3289-0

Ejemplares similares